Sex-specific proteome differences in the anterior cingulate cortex of schizophrenia

Journal of Psychiatric Research

Volumn 44, Issue 14, 2010, Pages 989-991

  Martins de Souza, Daniel ^a,c   Schmitt, Andrea ^b,c   Röder, Ruth ^a   Lebar, Maria ^a   Schneider Axmann, Thomas ^b   Falkai, Peter ^b   Turck, Christoph W ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anterior cingulate cortex; Biomarkers; Mass spectrometry; Proteome; Proteomics; Schizophrenia; Two dimensional gel electrophoresis

Indexed keywords

ALDOLASE C; ALPHA CRYSTALLIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; FRUCTOSE BISPHOSPHATE ALDOLASE; GLUTAMATE AMMONIA LIGASE; GLUTAMIC ACID; GLUTAMINE; PROTEOME; UNCLASSIFIED DRUG;

ARTICLE; AUTOPSY; CINGULATE GYRUS; CYTOSKELETON; DISEASE MARKER; GLYCOLYSIS; HUMAN; HUMAN TISSUE; MASS SPECTROMETER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SCHIZOPHRENIA; SEX DIFFERENCE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOTTING, WESTERN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; FRUCTOSE-BISPHOSPHATE ALDOLASE; GLUTAMATE-AMMONIA LIGASE; GYRUS CINGULI; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; NERVE TISSUE PROTEINS; POSTMORTEM CHANGES; PROTEOME; SCHIZOPHRENIA; SEX FACTORS;

EID: 77956303541     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2010.03.003     Document Type: Article

References (26)

1. Beasley C.L., Pennington K., Behan A., Wait R., Dunn M.J., Cotter D. Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease-associated changes. Proteomics 2006, 6(11):3414-3425.
2. Benes F.M., Bird E.D. An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients. Archives of General Psychiatry 1987, 44(7):608-616.
3. Benes F.M. Neurobiological investigations in cingulate cortex of schizophrenic brain. Schizophrenia Bulletin 1993, 19(3):537-549.
4. Benitez-King G., Ramírez-Rodríguez G., Ortíz L., Meza I. The neuronal cytoskeleton as a potential therapeutical target in neurodegenerative diseases and schizophrenia. Current drug targets. CNS and Neurological Disorders 2004, 3(6):515-533.
5. Carter C.S., Barch D.M. Attention, memory and language disturbances in schizophrenia: characteristics and implications. Advances in psychiatry 2000, vol. 3:45-72. Oxford Univ. Press, London/New Delhi. C. Andrade (Ed.).
6. Carter C.S., MacDonald A.W., Ross L.L., Stenger V.A. Anterior cingulate cortex activity and impaired self-monitoring of performance in patients with schizophrenia: an event-related fMRI study. The American Journal of Psychiatry 2001, 158:1423-1428.
7. 2O PET study during single-trial Stroop task performance. The American Journal of Psychiatry 1997, 154(12):1670-1675.
8. Chen J.W., Dodia C., Feinstein S.I., Jain M.K., Fisher A.B. 1-Cys peroxiredoxin, a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities. The Journal of Biological Chemistry 2000, 275(37):28421-28427.
9. Clark D., Dedova I., Cordwell S., Matsumoto I. A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia. Molecular Psychiatry 2006, 11(5):459-470. 423.
10. Freedman R. Schizophrenia. The New England Journal of Medicine 2003, 349:1738-1749.
11. Gattaz W.F., Brunner J. Phospholipase A2 and the hypofrontality hypothesis of schizophrenia. Prostaglandins, Leukotrienes, and Essential Fatty Acids 1996, 55(1-2):109-113.
12. Hwu H.G., Liu C.M., Fann C.S., Ou-Yang W.C., Lee S.F. Linkage of schizophrenia with chromosome 1q loci in Taiwanese families. Molecular Psychiatry 2003, 8(4):445-452.
13. Link C.D., Taft A., Kapulkin V., Duke K., Kim S., Fei Q., Wood D.E., Sahagan B.G. Gene expression analysis in a transgenic Caenorhabditis elegans Alzheimer's disease model. Neurobiology of Aging 2003, 24(3):397-413.
14. Luu P., Posner M.I. Anterior cingulate cortex regulation of sympathetic activity. Brain 2003, 126:2119-2120.
15. Martins-de-Souza D. Proteome and transcriptome analysis suggests oligodendrocyte dysfunction in schizophrenia. Journal of Psychiatric Research 2010, 44:149-156.
16. Martins-de-Souza D., Dias-Neto E., Schmitt A., Falkai P., Gormanns P., Maccarrone G., et al. Proteome analysis of schizophrenia brain tissue. The World Journal of Biological Psychiatry 2010, 11(2):110-120.
17. Martins-de-Souza D., Gattaz W.F., Schmitt A., Maccarrone G., Hunyadi-Gulyás E., Eberlin M.N., et al. Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. Journal of Psychiatric Research 2009, 43:978-986.
18. Martins-de-Souza D., Gattaz W.F., Schmitt A., Rewerts C., Marangoni S., Novello J.C., et al. Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis. Journal of Neural Transmission 2009, 116:275-289.
19. Martins-de-Souza D., Gattaz W.F., Schmitt A., Novello J.C., Marangoni S., Turck C.W., Dias-Neto E. Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation. BMC Psychiatry 2009, 9:17.
20. Shimizu S., Matsuzaki S., Hattori T., Kumamoto N., Miyoshi K., Katayama T., Tohyama M. DISC1-kendrin interaction is involved in centrosomal microtubule network formation. Biochemical and Biophysical Research Communications 2008, 377(4):1051-1056.
21. Sinclair C., Mirakhur M., Kirk J., Farrell M., McQuaid S. Up-regulation of osteopontin and alphaBeta-crystallin in the normal-appearing white matter of multiple sclerosis: an immunohistochemical study utilizing tissue microarrays. Neuropathology and Applied Neurobiology 2005, 31(3):292-303.
22. Strkalj Ivezić S., John N. Gender and schizophrenia. Psychiatria Danubina 2009, 21:106-110.
23. Tamminga C.A., Vogel M., Gao X., Lahti A.C., Holcomb H.H. The limbic cortex in schizophrenia: focus on the anterior cingulate. Brain Research Brain Research Reviews 2000, 31(2-3):364-370.
24. Tamminga C.A. Gender and schizophrenia. Journal of Clinical Psychiatry 1997, 58:33-37.
25. Tamminga C.A. Schizophrenia and glutamatergic transmission. Critical Reviews in Neurobiology 1998, 12:21-36.
26. van Os J., Kapur S. Schizophrenia. Lancet 2009, 374(9690):635-645.